Track S R L

Sirolimus Eluting Coronary Stent (SRL) L 605 cobalt-chromium stent platform with open and closed cell design. Unique stent design and strut locking mechanism offers excellent radial strength and minimal recoil. Uniform neointimal coverage and improved stent apposition. Completely biodegradable, biocompatible polymer (PLA carrier) 2 -Loading dose density of 1.20 g/mm 3 m - uniform coating thickness with precisely programmed release kinetics. Complete endothelization within180 days for drug release. In presence of drug how complete endothelialization happened. 90% of sirolimus is released within 90 to 120 days. Inhibits in-stent restenosis (ISR) and late stent thrombosis with adequate re- endothelialization. Designed for utmost safety - Track SRL displays one of the lowest entry profiles. Hydrophilic coated stent delivery system. Available Stent Lengths 10, 13, 15, 18, 20, 24, 28, 32, 36, 40, 44 and 48mm Available Stent Diameters 2.25, 2.50, 2.75, 3.00, 3.50 and 4.00mm Stent Design Open and closed Stent Platform Co Cr (L605 Cobalt Chromium) Stent Strut Thickness 63µm Stent Foreshortening Recoil Drug Sirolimus Delivery System Hydrophilic Coated Polymer Type Biodegradables (PLA) Coating Thickness 3µm About the Company Legal Status of Firm: Limited Company Number of Employees: 11 To 25 People Annual Turnover: 5 - 25 Cr company-description: Sah Health Care Pvt. Ltd. Was Established in 2020. We Are Specialized in Developing, Manufacturing and Trader the High-tech Medical Devices and Equipment. Today Sah Health Care Pvt. Ltd Has Grown Into a Leading Company in the Fields of Cardiovascular Interventions and Structural Heart Diseases. The Company Upholds "focusing on Quality, Respect for Life", Dedicating to Becoming One of the Leading Suppliers of Cardiovascular Interventions Equipment's in the Whole World.